RETRACTED: Hamycin (cas 1403-71-0) treatment of candidiasis in normal and diabetic rats

Add time:09/06/2019    Source:sciencedirect.com

This article has been retracted by agreement between the journal Chief Editor, Patrik Bavoil, Elsevier and Wiley-Blackwell. The author has been notified. Please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).Reason: The retraction has been agreed due to significant overlap between this article and the following article published in Antimicrobial Agents and Chemotherapy: 'Fluconazole (UK-49,858) Treatment of Candidiasis in Normal and Diabetic Rats' by Melanie A. Fisher, P. Gregory Lee and William F. Tarry. Antimicrob. Agents Chemother.,, 33 (1989) 1042–1045.The retraction has also been published by Wiley-Blackwell, doi:10.1111/j.1574-695X.2008.00432.x.

We also recommend Trading Suppliers and Manufacturers of Hamycin (cas 1403-71-0). Pls Click Website Link as below: cas 1403-71-0 suppliers

Prev:Regular ArticleMannose-Coated Liposomal Hamycin (cas 1403-71-0) in the Treatment of Experimental Leishmaniasis in Hamsters
Next:RETRACTED: Aerosolised liposomal Hamycin (cas 1403-71-0) for treatment of systemic Candida infections in mice)